CN103908539A - 一种治疗高血压的中药组合物及其制备方法及应用 - Google Patents
一种治疗高血压的中药组合物及其制备方法及应用 Download PDFInfo
- Publication number
- CN103908539A CN103908539A CN201410180355.3A CN201410180355A CN103908539A CN 103908539 A CN103908539 A CN 103908539A CN 201410180355 A CN201410180355 A CN 201410180355A CN 103908539 A CN103908539 A CN 103908539A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- rhizoma alismatis
- semen cassiae
- spica prunellae
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 97
- 239000000203 mixture Substances 0.000 title claims abstract description 86
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 53
- 238000002360 preparation method Methods 0.000 title claims description 13
- 210000000582 semen Anatomy 0.000 claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 23
- 239000006187 pill Substances 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 239000008187 granular material Substances 0.000 claims abstract description 6
- 239000007902 hard capsule Substances 0.000 claims abstract description 5
- 238000011282 treatment Methods 0.000 claims description 47
- 241000628997 Flos Species 0.000 claims description 31
- 239000000843 powder Substances 0.000 claims description 25
- 229940079593 drug Drugs 0.000 claims description 12
- 230000001631 hypertensive effect Effects 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 239000012467 final product Substances 0.000 claims description 8
- 208000007530 Essential hypertension Diseases 0.000 claims description 7
- 230000006837 decompression Effects 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- 238000005469 granulation Methods 0.000 claims description 7
- 230000003179 granulation Effects 0.000 claims description 7
- 208000029078 coronary artery disease Diseases 0.000 claims description 4
- -1 sieve Substances 0.000 claims description 3
- 239000002671 adjuvant Substances 0.000 claims description 2
- 239000002398 materia medica Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 235000007516 Chrysanthemum Nutrition 0.000 abstract description 10
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 20
- 239000008280 blood Substances 0.000 description 20
- 230000036772 blood pressure Effects 0.000 description 20
- 201000010099 disease Diseases 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 208000024891 symptom Diseases 0.000 description 14
- 230000035487 diastolic blood pressure Effects 0.000 description 12
- 230000007423 decrease Effects 0.000 description 10
- 241000723353 Chrysanthemum Species 0.000 description 9
- 241000700159 Rattus Species 0.000 description 9
- 239000013641 positive control Substances 0.000 description 9
- 230000035488 systolic blood pressure Effects 0.000 description 9
- 208000002173 dizziness Diseases 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 6
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 5
- 206010022437 insomnia Diseases 0.000 description 5
- 206010019280 Heart failures Diseases 0.000 description 4
- 206010044565 Tremor Diseases 0.000 description 4
- 150000001450 anions Chemical class 0.000 description 4
- 235000019658 bitter taste Nutrition 0.000 description 4
- 206010013781 dry mouth Diseases 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 206010025482 malaise Diseases 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 238000009530 blood pressure measurement Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000009532 heart rate measurement Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000000630 rising effect Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 238000013300 spontaneous hypertensive rat model Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
- 208000020446 Cardiac disease Diseases 0.000 description 1
- 206010007572 Cardiac hypertrophy Diseases 0.000 description 1
- 208000006029 Cardiomegaly Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000406668 Loxodonta cyclotis Species 0.000 description 1
- 206010028347 Muscle twitching Diseases 0.000 description 1
- 206010029412 Nightmare Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010042957 Systolic hypertension Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000000739 chaotic effect Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 239000003433 contraceptive agent Substances 0.000 description 1
- 230000002254 contraceptive effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000003777 experimental drug Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 210000003677 hemocyte Anatomy 0.000 description 1
- 229940000351 hemocyte Drugs 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 238000009592 kidney function test Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005857 malignant hypertension Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000001797 obstructive sleep apnea Diseases 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000001002 parasympathetic nervous system Anatomy 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000036513 peripheral conductance Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000001603 reducing effect Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000001202 rhombencephalon Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
组别 | 给药前 | 药后28天 | 降幅 |
空白对照组 | 156.4±10.11 | 157.8±9.70* | 1.20±0.21 |
模型对照组 | 241.34±12.64 | 232.1±19.68 | 11.31±3.83 |
阳性对照组 | 224.66±10.23 | 163±16.43△ | 58.66±16.49△ |
本发明中药组合物组 | 235.66±19.32 | 165±16.11△ | 66.10±15.66△* |
本发明中药组合物去除菊花组 | 243±9.04 | 198.3±12.72△ | 56.52±19.05△ |
组别 | 给药前 | 药后28天 | 降幅 |
空白对照组 | 71.51±9.44 | 70.47±5.75 | 1.04±0.31 |
模型对照组 | 140.76±11.73 | 137.23±4.47 | 3.53±0.58 |
阳性对照组 | 137.34±14.07 | 92.21±7.79△ | 45.13±15.85△ |
本发明中药组合物组 | 137.56±10.37 | 83.34±5.27△ | 54.22±14.26△*# |
本发明中药组合物去除菊花组 | 136.66±17.97 | 91.35±4.77△ | 45.31±16.56△ |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410180355.3A CN103908539B (zh) | 2014-05-03 | 2014-05-03 | 一种治疗高血压的中药组合物及其制备方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410180355.3A CN103908539B (zh) | 2014-05-03 | 2014-05-03 | 一种治疗高血压的中药组合物及其制备方法及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103908539A true CN103908539A (zh) | 2014-07-09 |
CN103908539B CN103908539B (zh) | 2017-02-01 |
Family
ID=51034743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410180355.3A Expired - Fee Related CN103908539B (zh) | 2014-05-03 | 2014-05-03 | 一种治疗高血压的中药组合物及其制备方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103908539B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105362389A (zh) * | 2015-08-12 | 2016-03-02 | 彭婷婷 | 一种治疗高血压的中药 |
CN105616767A (zh) * | 2014-10-29 | 2016-06-01 | 梁振权 | 一种降血压的中药配方 |
CN116808119A (zh) * | 2023-03-29 | 2023-09-29 | 南京同仁堂药业有限责任公司 | 山菊降压胶囊及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI388345B (zh) * | 2005-06-27 | 2013-03-11 | Sankyo Co | 用於高血壓之預防或治療之包含血管緊張素ⅱ受體拮抗劑及鈣通道阻斷劑之固體劑型 |
CN1775253A (zh) * | 2005-11-18 | 2006-05-24 | 北京阜康仁生物制药科技有限公司 | 山楂降压制剂及新的制备方法 |
CN101433610A (zh) * | 2007-11-12 | 2009-05-20 | 上海卡乐康包衣技术有限公司 | 山菊降压包衣分散片及其制备方法 |
CN101972368B (zh) * | 2010-10-28 | 2012-11-07 | 赤峰天奇制药有限责任公司 | 山菊降压颗粒制备工艺 |
CN103655969B (zh) * | 2012-09-14 | 2018-11-06 | 江苏康缘药业股份有限公司 | 一种具有调节血压、血糖功能的中药组合物及其制备方法 |
CN103610850A (zh) * | 2013-11-20 | 2014-03-05 | 黄立新 | 一种治疗高脂血症的药物 |
-
2014
- 2014-05-03 CN CN201410180355.3A patent/CN103908539B/zh not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105616767A (zh) * | 2014-10-29 | 2016-06-01 | 梁振权 | 一种降血压的中药配方 |
CN105362389A (zh) * | 2015-08-12 | 2016-03-02 | 彭婷婷 | 一种治疗高血压的中药 |
CN116808119A (zh) * | 2023-03-29 | 2023-09-29 | 南京同仁堂药业有限责任公司 | 山菊降压胶囊及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103908539B (zh) | 2017-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102028900B (zh) | 一种治疗代谢综合征的中药及其制备方法 | |
CN100435831C (zh) | 治疗高血压、高血脂、肥胖症及更年期综合症的制剂及其制备方法 | |
CN102198262B (zh) | 一种治疗小儿轮状病毒性肠炎的中药制剂及其制备方法 | |
CN103027138A (zh) | 一种醒脾茶及其制作方法 | |
CN106214964A (zh) | 安神的中药制剂 | |
CN108524673A (zh) | 一种中药组合物及其应用 | |
CN103908539B (zh) | 一种治疗高血压的中药组合物及其制备方法及应用 | |
CN103585588A (zh) | 一种治疗小儿疳积病的中药组合物 | |
CN104524342B (zh) | 一种四降保元中药制剂及其膏剂的制备方法 | |
CN106075056A (zh) | 一种提高免疫力及改善胃肠功能的灵芝保健品及制备方法 | |
CN104383420A (zh) | 制备治疗失眠多梦药物制剂的方法 | |
CN104383421A (zh) | 用于失眠多梦的药物制剂 | |
CN104324134B (zh) | 一种改善微循环的中药组合物及其制备方法 | |
CN104208115A (zh) | 一种干檀香、苦荬菜制成的中药组合物 | |
CN101007153A (zh) | 天麻健脑药物 | |
CN103479895A (zh) | 一种舒心清脑中药组合物 | |
CN103550335B (zh) | 一种改善肝功能的中药组合物 | |
CN103393938B (zh) | 一种降血糖的中药组合物 | |
CN105770705A (zh) | 一种治疗儿童功能消化不良的药物制剂及其用途 | |
CN105194355A (zh) | 一种治疗原发性高血压的中药制剂 | |
CN105535587A (zh) | 一种治疗心肾不交型心悸失眠的中药制剂及其制备方法 | |
CN105833043A (zh) | 一种中药组合物在制备治疗原发性高血压药物中的用途 | |
CN116440224B (zh) | 一种中药组合物、制剂及制备方法 | |
CN102846792A (zh) | 一种用于痰湿体质的组合物及其制备方法和用途 | |
CN108743757A (zh) | 一种治疗失眠的中药组合物及其制备方法与应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Li Quanhao Inventor after: Wang Moru Inventor after: Fu Guilian Inventor before: Wang Hengxin |
|
COR | Change of bibliographic data | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20161201 Address after: 261500 Gaomi City people's Hospital of Shandong Province, 77 Town Street, Weifang, Shandong, Gaomi City Applicant after: Li Quanhao Applicant after: Wang Moru Applicant after: Fu Guilian Address before: 222001 Jiangsu Province, Lianyungang city Sinpo District Road Gui Juyuan Yingzhou District 16 Building 1 floor A5 No. 06 Lianyungang Zhiyuan pharmaceutical facade Technology Services Ltd. Applicant before: Wang Hengxin |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20170201 Termination date: 20170503 |